Success! You're on the list.

Success! You're on the list.

With $3.8M funding, this female-founded digital healthtech will help people with complex chronic conditions

Image credits: juli

US-based juli, a female-founded AI-powered digital health platform recently raised $3.8 million in a seed funding round. The financing round was led by Speedinvest, one of the most active early-stage venture capital firms in Europe that invested in Porotech, and IndyKite recently.

It was also co-led by Norrsken VC, a fund investing in startups solving the world’s biggest problems. Besides, SoftBank’s Vision Fund Emerge Program and Dieter Von Holtzbrinck Ventures also participated in the round.

Growth and scaleup plans

Working with the vision to improve care for chronic conditions, the investment will enable juli to scale its commercial team across the US, conduct clinical trials of the app, and acquire additional artificial intelligence talent.

“juli is helping patients, providers and employers identify behavioural triggers that worsen or improve the most hard-to-treat and complex chronic conditions, including asthma, migraines, depression and bipolar disorder,” said Bettina Hein, CEO and co-founder of Boston-based juli. “With the support of Speedinvest, Norrsken and our other investors, we will be able to expand our reach to improve patient health and lower health care costs.”

Tove Larrson, General Partner at Norrsken VC said, “We urgently need better tools to manage these conditions, and available technology must be leveraged to ensure wider access to management tools. By gathering data from various sources, and monitoring patterns and triggers using its intelligent AI-powered system, juli enables patients to live better lives, and helps to alleviate the pressure on healthcare systems. We look forward to working together with the juli team to tackle this massive challenge.”

“It is often experienced founders with a fresh perspective who manage to innovate where others just rely on the status quo,” said Michael Schuster, General Partner at Speedinvest. “The juli team brings so much experience from so many different fields to the table – especially their in-depth experience and expertise in working with data – that I am convinced they‘ll shake up digital healthcare for good!“

Helps people with chronic conditions

Founded by Bettina Duhrkoop, Bettina Hein (a serial software entrepreneur who founded Pixability, and SVOX AG), Joris Straatman, and Joseph Hayes, juli is targeted at people with chronic conditions.

Currently, chronic conditions are surging and affecting a larger number of people. It is putting immense pressure on healthcare systems. As per reports, 90% of US healthcare expenditures are caused due to chronic and mental health conditions.

juli uses AI to help patients and their caregivers make a complex, multifactorial condition worse and identify changes that can help avoid or alleviate a flareup.

Since its debut, juli has helped nearly 15,000 patients who have used the app to track data for chronic conditions. Already, the company has earned high-profile awards including Best New Company of 2021 by MassTLC. It has been selected by the US Department of Health and Human Services as one of 15 digital health startups to join the 2022 PandemicX Accelerator cohort. Furthermore, it is one of the nine companies selected into SoftBank Vision Fund’s Emerge Program for 2021.

Better life for people with chronic conditions

juli is a management platform that empowers patients and their care teams to manage complex chronic conditions.

The AI-powered app combines patient-provided data, environmental data, and a patient’s social and behavioural context, to identify micro-behavioural changes that can improve their health.

juli supports patients with chronic health conditions like asthma, migraine, depression, bipolar disorder, and chronic pain through a number of evidence-based approaches, and uniquely unites multiple health data sources in one place. The app helps people with chronic conditions live better lives.

Related Posts

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you